Intelligence Search Intelligence Filter by: Industry Team Airport & AviationAutomotiveEmerging TechnologiesEnergy Food & BeverageHealth CareHospitality, Resort & GolfInsurance & Reinsurance Life SciencesMedical DevicesSports Practice Area Business Law All Business LawEmployee Benefits & Executive CompensationEnvironmental RegulationEstates & TrustsFinance & Financial InstitutionsHealth Care Finance Private Equity & Venture CapitalPublic FinanceReal EstateSecurities, Commodities & Exchange RegulationTaxationTransactional & Securities Government & Public Policy All Government & Public PolicyFDA RegulatoryGovernment ProcurementImmigration, Nationality & Consular Law NHTSA & Motor Vehicle SafetyPolitical LawPublic PolicySurface Transport Intellectual Property All Intellectual PropertyBusiness Method & Software PatentsChemical, Biotechnology & PharmaceuticalElectronicsGreen Energy TechnologiesInformation Technology & Outsourcing IP Due DiligenceIP LitigationMechanical & Electromechanical TechnologiesPatent Office TrialsTrademark, Copyright & Advertising Counseling International All InternationalChina EuropeJapan Litigation All LitigationAntitrustAppellateBankruptcy & Business ReorganizationsBusiness Litigation & Dispute ResolutionConstructionConsumer Financial Services Distribution & FranchiseGovernment Enforcement, Compliance & White Collar DefenseInsurance & Reinsurance LitigationLabor & EmploymentPrivacy, Security & Information ManagementSecurities Enforcement & LitigationTrade Secret Noncompete Litigation Topic Accountable Care OrganizationsAmerica Invents Act (Patent Reform)Consumer Protection Act Corporate GovernanceDodd–Frank Wall Street ReformExport Control/Economic Sanctions Foreign Corrupt Practices Act (FCPA)Health Care ReformPersonalized Medicine Type ArticleBlog Post BookNewsletter VideoWhite Paper Featured All Filters applied: Search phrase entered: Sort results by: Most Recent Most Viewed Most Shared Foley Blogs: CFSL Bulletin Cleantech & Nano Dashboard Insights Labor & Employment Law Perspectives Personalized Medicine Bulletin PharmaPatents Renewable Energy Outlook Wisconsin Appellate Law 12345next Supreme Court Finds for Monsanto in Seed Harvesting Case 16 May 2013 PharmaPatents In Bowman v. Monsanto Co., the Supreme Court held that the doctrine of patent exhaustion does not give a farmer who has bought patented seeds the right to “reproduce”... Federal Circuit Issues Fractured Affirmance in CLS Bank v. Alice Corporation 13 May 2013 PharmaPatents In a fractured en banc decision, the Federal Circuit affirmed the district court’s holding that the claims at issue in CLS Bank v. Alice Corporation are invalid... USPTO Reshuffles the RCE Deck 09 May 2013 PharmaPatents The USPTO still is considering information gathered during its RCE Outreach program, but it has made some internal changes that should lead to more prompt examination... Federal Circuit Upholds One Claim Covering Combigan 07 May 2013 PharmaPatents In Allergan, Inc. v. Sandoz, Inc., the Federal Circuit reversed the district court in part, finding that Allergan’s composition claims and most of its method claims... Federal Circuit Holds That Patent Indefiniteness Requires Insoluble Ambiguousness 02 May 2013 PharmaPatents In Biosig Instruments, Inc. v. Nautilus Inc., the Federal Circuit reversed the district court’s finding that the claims at issue were invalid as indefinite, because... Dispelling the Myriad Gene Patent Harmonization Myth 30 April 2013 PharmaPatents In the wake of the Supreme Court oral arguments in the Myriad “gene patent” case, most commentators are predicting that the Court will uphold the patent-eligibility... Federal Circuit Finds Yaz Patent Obvious 25 April 2013 PharmaPatents In Bayer Healthcare Pharmaceuticals, Inc. v. Watson Pharmaceuticals, Inc., the Federal Circuit reversed the district court and held that Bayer’s patent covering... Federal Circuit Finds Prosecution History Disclaimer in Enablement Arguments 23 April 2013 PharmaPatents In Biogen Idec, Inc. v. GlaxoSmithKline LLC, the Federal Circuit upheld a narrow claim interpretation based on prosecution history disclaimer. The court held that... Challenging the Enabling Quality of Prior Art 18 April 2013 PharmaPatents In In re Morsa, the Federal Circuit reversed an anticipation rejection where the applicant had challenged the enabling quality of the cited prior art reference,... Supreme Court Hears Oral Arguments in "ACLU/Myriad" Gene Patenting Case 15 April 2013 Legal News Alert: Intellectual Property On April 15, 2013, the Supreme Court heard oral arguments in one of the most controversial and publicized biotech patent cases, the “ACLU/Myriad” gene patenting... 12345next Related 1 2 3
Supreme Court Finds for Monsanto in Seed Harvesting Case 16 May 2013 PharmaPatents In Bowman v. Monsanto Co., the Supreme Court held that the doctrine of patent exhaustion does not give a farmer who has bought patented seeds the right to “reproduce”...
Federal Circuit Issues Fractured Affirmance in CLS Bank v. Alice Corporation 13 May 2013 PharmaPatents In a fractured en banc decision, the Federal Circuit affirmed the district court’s holding that the claims at issue in CLS Bank v. Alice Corporation are invalid...
USPTO Reshuffles the RCE Deck 09 May 2013 PharmaPatents The USPTO still is considering information gathered during its RCE Outreach program, but it has made some internal changes that should lead to more prompt examination...
Federal Circuit Upholds One Claim Covering Combigan 07 May 2013 PharmaPatents In Allergan, Inc. v. Sandoz, Inc., the Federal Circuit reversed the district court in part, finding that Allergan’s composition claims and most of its method claims...
Federal Circuit Holds That Patent Indefiniteness Requires Insoluble Ambiguousness 02 May 2013 PharmaPatents In Biosig Instruments, Inc. v. Nautilus Inc., the Federal Circuit reversed the district court’s finding that the claims at issue were invalid as indefinite, because...
Dispelling the Myriad Gene Patent Harmonization Myth 30 April 2013 PharmaPatents In the wake of the Supreme Court oral arguments in the Myriad “gene patent” case, most commentators are predicting that the Court will uphold the patent-eligibility...
Federal Circuit Finds Yaz Patent Obvious 25 April 2013 PharmaPatents In Bayer Healthcare Pharmaceuticals, Inc. v. Watson Pharmaceuticals, Inc., the Federal Circuit reversed the district court and held that Bayer’s patent covering...
Federal Circuit Finds Prosecution History Disclaimer in Enablement Arguments 23 April 2013 PharmaPatents In Biogen Idec, Inc. v. GlaxoSmithKline LLC, the Federal Circuit upheld a narrow claim interpretation based on prosecution history disclaimer. The court held that...
Challenging the Enabling Quality of Prior Art 18 April 2013 PharmaPatents In In re Morsa, the Federal Circuit reversed an anticipation rejection where the applicant had challenged the enabling quality of the cited prior art reference,...
Supreme Court Hears Oral Arguments in "ACLU/Myriad" Gene Patenting Case 15 April 2013 Legal News Alert: Intellectual Property On April 15, 2013, the Supreme Court heard oral arguments in one of the most controversial and publicized biotech patent cases, the “ACLU/Myriad” gene patenting...